| 1 | Approve Financial Statements and Statutory Reports
| Abstain |
| 2 | Approve Consolidated Financial Statements and Statutory Reports
| Abstain |
| 3 | Approve Allocation of Income and Dividends of EUR 0.25 per Share With an Option for Payment of Dividends in Cash or in Shares
| For |
| 4 | Approve Related Party Approve Auditors' Special Report on Related-Party Transactions
| For |
| 5 | Re-Elect Bi Yong Chungunco - Non-Executive Director | For |
| 6 | Re-Elect Clotilde Delbos - Non-Executive Director | For |
| 7 | Re-Elect Baudouin Prot - Non-Executive Director | For |
| 8 | Approve Remuneration Policy of Chairman and CEO
| Oppose |
| 9 | Approve Remuneration Policy of Directors
| For |
| 10 | Approve Compensation Report of Corporate Officers
| For |
| 11 | Approve Compensation of Henri Poupart-Lafarge, Chairman and CEO
| Oppose |
| 12 | Authorise Share Repurchase | Oppose |
| 13 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
| For |
| 14 | Authorize Capitalization of Reserves of Up to EUR 911 Million for Bonus Issue or Increase in Par Value
| For |
| 15 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 911 Million
| For |
| 16 | Issue Shares for Cash | Oppose |
| 17 | Authorize Capital Increase of Up to EUR 260 Million for Future Exchange Offers | Oppose |
| 18 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 260 Million
| Oppose |
| 19 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans
| Oppose |
| 20 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees of International Subsidiaries | Oppose |
| 21 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights
| Oppose |
| 22 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 15 to 20
| Oppose |
| 23 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| Oppose |
| 24 | Authorize Issuance of Equity upon Conversion of a Subsidiary's Equity-Linked Securities without Preemptive Rights for Up to EUR 260 Million
| Oppose |
| 25 | Authorize Filing of Required Documents/Other Formalities
| For |
